According to a Cleveland Clinic analysis, drug coated stents increase the risk of dangerous blood clots four to five times more than the bare metal stents. The analysis covered 6,675 patients in 9 trials involving Johnson & Johnson and Boston Scientific.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.